文章名稱引用次數(shù)

• Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival14
• Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group Report11
• High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results9
• Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-1038
• Using a surgical prostate-specific antigen threshold of >0.2 ng/mL to define biochemical failure for intermediate- and high-risk prostate cancer patients treated with definitive radiation therapy in the ASCENDE-RT randomized control trial7
• Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer6
• Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer6
• Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS)5
• Time-resolved in vivo dosimetry for source tracking in brachytherapy5
• Improved survival for patients with prostate cancer receiving high-dose-rate brachytherapy boost to EBRT compared with EBRT alone4